Video: Risk Management of Adventitious Agent Contamination in Biopharmaceutical Products
Feb 29, 2012
Untitled Document
During this podcast, we will discuss the causes and implications of Adventitious Agent Contamination for pharmaceutical and biopharmaceutical manufacturers. We will discuss ways in which Lancaster Laboratories is helping manufacturers minimize the risk for this contamination to avoid production delays.
Presenter: Jeri Ann Boose, Ph.D.
Director, Biopharmaceutical Services
Lancaster Laboratories
